Intravitreal administration

Results: 30



#Item
11UIR[removed]V2.1  Guidelines for Performing Intravitreal Therapy _______________________________________________________________________________

UIR[removed]V2.1 Guidelines for Performing Intravitreal Therapy _______________________________________________________________________________

Add to Reading List

Source URL: ranzco.edu

Language: English - Date: 2014-06-10 23:41:32
12UIR[removed]V2.1  Instructions for patients following intravitreal injection Name:  …………………………………………………………

UIR[removed]V2.1 Instructions for patients following intravitreal injection Name: …………………………………………………………

Add to Reading List

Source URL: www.ranzco.edu

Language: English - Date: 2014-06-10 23:41:32
13UIR[removed]V2.1  Guidelines for Performing Intravitreal Therapy _______________________________________________________________________________

UIR[removed]V2.1 Guidelines for Performing Intravitreal Therapy _______________________________________________________________________________

Add to Reading List

Source URL: www.ranzco.edu

Language: English - Date: 2014-06-10 23:41:32
14tified in this clinical situation. Justification for a randomized clinical trial usually includes the following8: (1) evidence of a significant public health problem, (2) a scientifically plausible intervention, (3) prel

tified in this clinical situation. Justification for a randomized clinical trial usually includes the following8: (1) evidence of a significant public health problem, (2) a scientifically plausible intervention, (3) prel

Add to Reading List

Source URL: www.zora.uzh.ch

Language: English - Date: 2010-11-29 13:06:16
15NDA[removed]S-010 Page 4 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information ®

NDA[removed]S-010 Page 4 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information ®

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-09-29 13:17:40
16Food and Drug Administration Center for Drug Evaluation and Research Division of Transplant and Ophthalmology Products Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Briefing Package

Food and Drug Administration Center for Drug Evaluation and Research Division of Transplant and Ophthalmology Products Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Briefing Package

Add to Reading List

Source URL: www.fda.gov

Language: English
17Quark Clinical Experience with Synthetic siRNAs u Overview of Quark development programs u Summary of nonclinical and clinical experience in the eye following local (intravitreal) administration

Quark Clinical Experience with Synthetic siRNAs u Overview of Quark development programs u Summary of nonclinical and clinical experience in the eye following local (intravitreal) administration

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-08 14:18:40
18Steerable Intravitreal Inserts for Drug Delivery: In Vitro and Ex Vivo Mobility Experiments Christos Bergeles1 , Michael P. Kummer1 , Bradley E. Kratochvil1, Carsten Framme2 , and Bradley J. Nelson1 1

Steerable Intravitreal Inserts for Drug Delivery: In Vitro and Ex Vivo Mobility Experiments Christos Bergeles1 , Michael P. Kummer1 , Bradley E. Kratochvil1, Carsten Framme2 , and Bradley J. Nelson1 1

Add to Reading List

Source URL: robotics.tch.harvard.edu

Language: English - Date: 2012-10-08 11:47:12
19OFFICE OF CLINICAL PHARMACOLOGY REVIEW NDA:  [removed]

OFFICE OF CLINICAL PHARMACOLOGY REVIEW NDA: [removed]

Add to Reading List

Source URL: www.fda.gov

Language: English
20Intravitreal Sustained Release Ganciclovir

Intravitreal Sustained Release Ganciclovir

Add to Reading List

Source URL: www.fda.gov

Language: English